Oral Muco Rinse
Natural health product licensed in Canada
- Licence holder
- SciQReg Consulting
- NPN or DIN-HM
- 80051404
- Status
- Active licence
- Licence date
- 3 June 2014
- Revision date
- Not provided
- Form
- Gargarismes
- Route of administration
- Buccale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Phosphate de sodium dibasique Source : Phosphate de sodium dibasique | 0.032 % |
| Phosphate de sodium dibasique Source : Phosphate de sodium dibasique | 0.633 mg |
| Chlorure de sodium Source : Chlorure de sodium | 0.285 % |
| Chlorure de sodium Source : Chlorure de sodium | 5.693 mg |
Non-medicinal ingredients
Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 dose | 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps treat the severity, duration and pain associated with oral mucositis caused by chemotherapy and/or radiation therapy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051404
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.